✦ LIBER ✦

Mass screening for neuroblastoma at 6 months of age – Authors' reply

✍ Scribed by Eiso Hiyama; Tomoko Iehara

Book ID: 117303373
Publisher: The Lancet
Year: 2008
Tongue: English
Weight: 43 KB
Volume: 372
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(08)61156-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mass screening for neuroblastoma at 6 mo

Mass screening for neuroblastoma at 6 months of age

✍ Yuji Miura; Masahiro Kami; Masaharu Tsubokura; Naoko Takei; Tsunehiko Komatsu 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 50 KB

Mass screening for neuroblastoma at 6 mo

Mass screening for neuroblastoma at 6 months of age: Difficult to justify

✍ S Suita; T Tajiri; K Akazawa; Y Sera; H Takamatsu; H Mizote; H Ohgami; N Kurosak 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Risks and benefits of ending of mass scr

Risks and benefits of ending of mass screening for neuroblastoma at 6 months of age in Japan

✍ Tatsuro Tajiri; Ryota Souzaki; Yoshiaki Kinoshita; Sakura Tanaka; Yuhki Koga; Ai 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Results for 79 patients with neuroblasto

Results for 79 patients with neuroblastoma detected through mass screening at 6 months of age in a single institute

✍ NOBUHIRO NISHIO; JUN-ICHI MIMAYA; TAEMI NARA; YOSHIFUMI TAKASHIMA; YASUO HORIKOS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Effectiveness of screening for neuroblas

Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study

✍ Eiso Hiyama; Tomoko Iehara; Tohru Sugimoto; Masahiro Fukuzawa; Yutaka Hayashi; F 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 108 KB

German neuroblastoma mass screening stud

German neuroblastoma mass screening study at 12 months of age: statistical aspects and preliminary results

✍ Schilling, Freimut H.; Spix, Claudia; Berthold, Frank; Erttmann, Rudolf; Hero, B 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

Background. The question of whether screening for neuroblastoma (NB) results in a substantial improvement of the prognosis of the disease is still open. All data, including those of the European pilot studies, indicate the possibility of overdiagnosis in the case of possibly spontaneously regressing